HRP950115B1 - The use of carboxylic acid derivatives as medicaments - Google Patents

The use of carboxylic acid derivatives as medicaments

Info

Publication number
HRP950115B1
HRP950115B1 HR950115A HRP950115A HRP950115B1 HR P950115 B1 HRP950115 B1 HR P950115B1 HR 950115 A HR950115 A HR 950115A HR P950115 A HRP950115 A HR P950115A HR P950115 B1 HRP950115 B1 HR P950115B1
Authority
HR
Croatia
Prior art keywords
pct
medicaments
carboxylic acid
acid derivatives
sec
Prior art date
Application number
HR950115A
Other languages
English (en)
Inventor
Ernst Baumann
Uwe Josef Vogelbacher
Joachim Rheinheimer
Dagmar Klinge
Hartmut Riechers
Burghard Kroeger
Siegfried Bialojan
Claus Bollschweiler
Wolfgang Wernet
Liliane Unger
Manfred Raschack
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of HRP950115A2 publication Critical patent/HRP950115A2/hr
Publication of HRP950115B1 publication Critical patent/HRP950115B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
HR950115A 1994-03-31 1995-03-09 The use of carboxylic acid derivatives as medicaments HRP950115B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4411225A DE4411225A1 (de) 1994-03-31 1994-03-31 Verwendung von Carbonsäurederivaten als Arzneimittel

Publications (2)

Publication Number Publication Date
HRP950115A2 HRP950115A2 (en) 1997-10-31
HRP950115B1 true HRP950115B1 (en) 2001-12-31

Family

ID=6514334

Family Applications (1)

Application Number Title Priority Date Filing Date
HR950115A HRP950115B1 (en) 1994-03-31 1995-03-09 The use of carboxylic acid derivatives as medicaments

Country Status (28)

Country Link
US (1) US5840722A (xx)
EP (1) EP0752854B1 (xx)
JP (2) JP4001622B2 (xx)
KR (1) KR100365629B1 (xx)
CN (1) CN1070701C (xx)
AT (1) ATE204471T1 (xx)
AU (1) AU695193B2 (xx)
BR (1) BR9507231A (xx)
CA (1) CA2186784C (xx)
CZ (1) CZ290684B6 (xx)
DE (2) DE4411225A1 (xx)
DK (1) DK0752854T3 (xx)
ES (1) ES2162916T3 (xx)
FI (1) FI118589B (xx)
GR (1) GR3036606T3 (xx)
HR (1) HRP950115B1 (xx)
HU (1) HU228063B1 (xx)
IL (1) IL113137A (xx)
NO (1) NO310497B1 (xx)
NZ (1) NZ283333A (xx)
PL (1) PL179580B1 (xx)
PT (1) PT752854E (xx)
RU (1) RU2163808C2 (xx)
SI (1) SI9520048A (xx)
TW (1) TW382594B (xx)
UA (1) UA44734C2 (xx)
WO (1) WO1995026716A1 (xx)
ZA (1) ZA952614B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4411225A1 (de) * 1994-03-31 1995-10-05 Basf Ag Verwendung von Carbonsäurederivaten als Arzneimittel
DE19533023B4 (de) * 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
DE19536891A1 (de) * 1995-10-04 1997-04-10 Basf Ag Neue Aminosäurederivate, ihre Herstellung und Verwendung
DE19614533A1 (de) 1996-04-12 1997-10-16 Basf Ag Neue alpha-Hydroxysäurederivate, ihre Herstellung und Verwendung
DE19636046A1 (de) * 1996-09-05 1998-03-12 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten
US6030975A (en) * 1997-03-14 2000-02-29 Basf Aktiengesellschaft Carboxylic acid derivatives, their preparation and use in treating cancer
DE19726146A1 (de) * 1997-06-19 1998-12-24 Basf Ag Neue ß-Amino und ß-Azidopcarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten
SK1522000A3 (en) * 1997-09-04 2000-08-14 Basf Ag Novel carboxylic acid derivatives, their production and their use as mixed eta/etb endothelin-receptor antagonists
BR9814951A (pt) 1997-10-31 2000-10-03 Basf Ag Derivado de ácido carboxìlico, uso do mesmo, preparação de medicamento para o uso oral, parenteral, combinação, uso de compostos, fragmento estrutural, uso do mesmo, antagonista de receptor de endotelina, e, composto
DE19806438A1 (de) * 1998-02-17 1999-08-19 Basf Ag Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung
DE19809144A1 (de) * 1998-03-04 1999-09-09 Basf Ag Neue unsymmetrisch substituierte Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶LAMBDA¶/ET¶B¶-Rezeptorantagonisten
DE19809635A1 (de) 1998-03-06 1999-09-09 Basf Ag Verfahren zur Darstellung von Endothelinrezeptorantagonisten vom Sulfanyltyp
US7566452B1 (en) 1999-05-04 2009-07-28 New York University Cancer treatment with endothelin receptor antagonists
WO2002064573A1 (de) * 2001-02-14 2002-08-22 Abbott Gmbh & Co. Kg Neue carbonsäurederivate mit alkylsubstituierten triazinen, ihre herstellung und verwendung als endothelin-rezeptorantagonisten
US20040204422A1 (en) 2003-04-14 2004-10-14 Abbott Gmbh & Co. Kg. N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
EP2118073A2 (en) * 2007-02-02 2009-11-18 Concert Pharmaceuticals Inc. Selective endothelin type-a antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69226813T2 (de) * 1991-06-07 1999-02-18 Ube Industries Pyrimidin- oder Triazin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Herbizide
DE4313412A1 (de) * 1993-04-23 1994-10-27 Basf Ag 3-(Het)aryl-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung
DE4411225A1 (de) * 1994-03-31 1995-10-05 Basf Ag Verwendung von Carbonsäurederivaten als Arzneimittel

Also Published As

Publication number Publication date
NO964121D0 (no) 1996-09-27
US5840722A (en) 1998-11-24
MX9604448A (es) 1997-07-31
DE4411225A1 (de) 1995-10-05
NO964121L (no) 1996-11-26
CN1070701C (zh) 2001-09-12
JP4001622B2 (ja) 2007-10-31
JPH09510984A (ja) 1997-11-04
DE59509537D1 (de) 2001-09-27
WO1995026716A1 (de) 1995-10-12
TW382594B (en) 2000-02-21
HUT75305A (en) 1997-05-28
GR3036606T3 (en) 2001-12-31
BR9507231A (pt) 1997-09-16
FI963885A (fi) 1996-11-26
IL113137A0 (en) 1995-06-29
PL316563A1 (en) 1997-01-20
ZA952614B (en) 1996-09-30
CA2186784A1 (en) 1995-10-12
FI963885A0 (fi) 1996-09-27
NO310497B1 (no) 2001-07-16
ES2162916T3 (es) 2002-01-16
CZ287396A3 (en) 1997-04-16
EP0752854A1 (de) 1997-01-15
DK0752854T3 (da) 2001-10-08
HU228063B1 (en) 2012-09-28
EP0752854B1 (de) 2001-08-22
NZ283333A (en) 1997-02-24
ATE204471T1 (de) 2001-09-15
JP4769742B2 (ja) 2011-09-07
HRP950115A2 (en) 1997-10-31
CN1148807A (zh) 1997-04-30
KR100365629B1 (ko) 2003-04-10
UA44734C2 (uk) 2002-03-15
FI118589B (fi) 2008-01-15
HU9602695D0 (en) 1996-11-28
KR970702042A (ko) 1997-05-13
IL113137A (en) 1999-10-28
PT752854E (pt) 2002-02-28
CZ290684B6 (cs) 2002-09-11
PL179580B1 (pl) 2000-09-29
AU2135695A (en) 1995-10-23
SI9520048A (en) 1997-02-28
AU695193B2 (en) 1998-08-06
RU2163808C2 (ru) 2001-03-10
JP2007131645A (ja) 2007-05-31
CA2186784C (en) 2007-02-20

Similar Documents

Publication Publication Date Title
HRP950115B1 (en) The use of carboxylic acid derivatives as medicaments
GR3024074T3 (en) Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar).
CZ208895A3 (en) Novel imidazopyridine compounds, process for preparing such compounds and their salts, the use of said compounds and salts in the preparation of medicaments and a medicament containing thereof
MX9701538A (es) Sales de un derivado del indol contra la migraña.
TW263499B (xx)
AU699480B2 (en) 2,2-Dichloroalkane carboxylic acids, processes for their production and pharmaceutical agents containing these
ZA9429B (en) Pyrrolidine derivatives their preparation and medicaments containing them
NZ292934A (en) Amino substituted indole ether derivatives and medicaments
IL112763A0 (en) New n-benzoylmethyl-piperidines
TW261605B (xx)
ZA9480B (en) Pyrrolidine derivatives their preparation and medicaments containing them
HU9600606D0 (en) Process for the preparation of indolizine derivatives

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
PPPP Transfer of rights

Owner name: ABBOTT GMBH & CO. KG, DE

PPPP Transfer of rights

Owner name: ABBVIE DEUTSCHLAND GMBH & CO. KG, DE

ODRP Renewal fee for the maintenance of a patent

Payment date: 20140227

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20150309